小児IgA血管炎診療ガイドライン2023ダイジェスト

• 資料種別: 記事
• タイトル: 小児IgA血管炎診療ガイドライン2023ダイジェスト
• 著者標目: 清水 正樹; 野津 寛大; 亀井 宏一; 新井 達; 安斎 眞一; 五十嵐 徹; 石毛 崇; 漆原 真樹; 大田 敏之; 岡 政史; 島 友子; 神保 圭佑; 敦賀 和志; 濱田 陸; 平野 大志; 宮前 多佳子; 山本 雅紀; 阿部 祥英; 荒木 潤一郎; 井藤 奈央子; 梅田 千里; 岡本 孝之; 金子 修也; 加納 優治; 久保田 知洋; 倉岡 将平; 倉田 悟子; 坂井 智行; 櫻谷 浩志; 篠塚 俊介; 島袋 渡; 白川 利彦; 高木 陽子; 高橋 弘典; 龍城 真衣子; 田中 絵里子; 田中 一樹; 寺野 千香子; 泊 弘毅; 忍頂寺 毅史; 伴 英樹; 藤田 雄治; 藤原 香緒里; 堀之内 智子; 松岡 大輔; 松村 壮史; 宮井 貴之; 三輪 沙織; 村越 未希; 安村 純子; 山村 智彦; 山本 かずな; 金子 一成
• 出版年月日等: 2025
• 出版年（W3CDTF）: 2025
• タイトル（掲載誌）: 日児腎誌
• 巻号年月日等（掲載誌）: 38 0
• 掲載巻: 38
• 掲載号: 0
• 掲載ページ: n/a-
• 掲載年月日（W3CDTF）: 2025
• ISSN（掲載誌）: 09152245
• ISSN-L（掲載誌）: 09152245
• 出版事項（掲載誌）: The Japanese Society for Pediatric Nephrology
• 本文の言語コード: ja
• 件名標目: IgA vasculitis; IgA vasculitis nephritis; Guideline; IgA血管炎; 紫斑病性腎炎; ガイドライン
• 対象利用者: 一般
• DOI: 10.3165/jjpn.sc.25-007; https://doi.org/10.3165/jjpn.sc.25-007
• 関連情報（URI）: https://www.jstage.jst.go.jp/article/jjpn/38/0/38_sc.25-007/_pdf; https://search.jamas.or.jp/link/ui/2025340480
• 参照: Even mild cases of paediatric <scp>H</scp>enoch‐<scp>S</scp>chönlein purpura nephritis show significant long‐term proteinuria; https://cir.nii.ac.jp/crid/1360013171791017088; Management of intestinal bleeding with single‐dose cyclophosphamide in Henoch–Schönlein purpura; https://cir.nii.ac.jp/crid/1360016866057489920; Púrpura de Schönlein-Henoch Buloso. Caso clínico; https://cir.nii.ac.jp/crid/1360024022681628672; Posterior reversible encephalopathy syndrome in Henoch–Schönlein purpura; https://cir.nii.ac.jp/crid/1360024022784164352; Azathioprine therapy for steroid-resistant Henoch-Schönlein purpura: a report of 6 cases; https://cir.nii.ac.jp/crid/1360024024145101568; Masked severe stenosing ureteritis: a rare complication of Henoch-Schönlein purpura; https://cir.nii.ac.jp/crid/1360024025339514880; Massive gastrointestinal haemorrhage in isolated intestinal Henoch-Schonlein purpura with response to intravenous immunoglobulin infusion; https://cir.nii.ac.jp/crid/1360024026171376000; Immunoglobulin A vasculitis without purpura in an elderly female patient: a case report; https://cir.nii.ac.jp/crid/1360024026753351808; Pulmonary function abnormalities in children with Henoch-Schonlein purpura; https://cir.nii.ac.jp/crid/1360024026781970176; Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide; https://cir.nii.ac.jp/crid/1360292619068121600; European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis—the SHARE initiative; https://cir.nii.ac.jp/crid/1360294645269698944; Intravenous immunoglobulins for severe gastrointestinal involvement in pediatric Henoch-Schönlein purpura: A French retrospective study; https://cir.nii.ac.jp/crid/1360298343932788608; Clinical outcome in pediatric refractory gastrointestinal Henoch-Schönlein purpura treated with mycophenolate mofetil; https://cir.nii.ac.jp/crid/1360298344792232064; Effect and safety evaluation of tacrolimus and tripterygium glycosides combined therapy in treatment of Henoch–Schönlein purpura nephritis; https://cir.nii.ac.jp/crid/1360302870446759680; Gallbladder and Pancreas in Henoch‐Schönlein Purpura; https://cir.nii.ac.jp/crid/1360305499141682560; Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study; https://cir.nii.ac.jp/crid/1360305500105747968; Henoch–Schonlein purpura with high factor VIII levels and deep venous thrombosis: an association or coincidence?; https://cir.nii.ac.jp/crid/1360305501125428224; Early prednisone therapy in Henoch-Schönlein purpura: A randomized, double-blind, placebo-controlled trial; https://cir.nii.ac.jp/crid/1360564063991284608; Treatment strategies for Henoch-Schönlein purpura nephritis by histological and clinical severity; https://cir.nii.ac.jp/crid/1360565165275285888; A randomized, placebo-controlled trial of prednisone in early Henoch Schönlein Purpura [ISRCTN85109383]; https://cir.nii.ac.jp/crid/1360574093919004928; Successful treatment of adult Henoch-Schönlein purpura with factor XIII concentrate; https://cir.nii.ac.jp/crid/1360574094175281280; Henoch-Schönlein purpura with acute pancreatitis: analysis of 13 cases; https://cir.nii.ac.jp/crid/1360574094241472384; Multisystemic manifestations of IgA vasculitis; https://cir.nii.ac.jp/crid/1360576122999071616; Steroid Effects on the Course of Abdominal Pain in Children With Henoch-Schonlein Purpura; https://cir.nii.ac.jp/crid/1360579819987661568; IgA vasculitis with nephritis: update of pathogenesis with clinical implications; https://cir.nii.ac.jp/crid/1360580236950551936; Childhood vasculitis and plasma exchange; https://cir.nii.ac.jp/crid/1360586971785118976; Cerebral vasculitis and intracerebral hemorrhage in Henoch-Sch�nlein purpura treated with plasmapheresis; https://cir.nii.ac.jp/crid/1360586971785119744; Biopsy-proven Henoch-Schönlein purpura nephritis: a single center experience; https://cir.nii.ac.jp/crid/1360586971785120768; Myocarditis and intracardiac thrombus due to Henoch-Schönlein purpura: case report and literature review; https://cir.nii.ac.jp/crid/1360586971785123072; Penile involvement of immunoglobulin a vasculitis/Henoch-Schönlein purpura; https://cir.nii.ac.jp/crid/1360586971785398784; Decreased Factor XIII Activity during Severe Henoch-Schoenlein Purpura - Does It Play a Role?; https://cir.nii.ac.jp/crid/1360586971785622784; Henoch-Schöenlein syndrome in Qatar: the effects of steroid therapy and paucity of renal involvement; https://cir.nii.ac.jp/crid/1360586971785641344; Gastrointestinal Henoch–Schönlein purpura successfully treated with Mycophenolate Mofetil; https://cir.nii.ac.jp/crid/1360586971785688704; Complicated <scp>H</scp>enoch–<scp>S</scp>chönlein purpura; https://cir.nii.ac.jp/crid/1360586971785918976; Treatment of Complicated Henoch-Schönlein Purpura with Mycophenolate Mofetil: A Retrospective Case Series Report; https://cir.nii.ac.jp/crid/1360586971785955456; Central Nervous System Involvement in Henoch‐Schonlein Purpura in Children and Adolescents; https://cir.nii.ac.jp/crid/1360586971785959040; Intravenous γ Globulin for Intractable Abdominal Pain due to IgA Vasculitis; https://cir.nii.ac.jp/crid/1360586971785963520; Recurrent Henoch-Schönlein Purpura with bullous rash and pulmonary nodules; https://cir.nii.ac.jp/crid/1360586971786003200; High-dose methylprednisolone pulse therapy for treatment of refractory intestinal involvement caused by Henoch–Schönlein purpura: a case report; https://cir.nii.ac.jp/crid/1360586971786090368; Henoch-Schönlein Purpura With Scrotal Involvement: A Case Report and Literature Review; https://cir.nii.ac.jp/crid/1360586972329225984; Cerebral hemorrhage in Henoch-Schoenlein syndrome; https://cir.nii.ac.jp/crid/1360586972544049792; Cardiac manifestations of Henoch-Schoenlein purpura: IgA mediated vasculitis or Rheumatic fever?; https://cir.nii.ac.jp/crid/1360586972544052864; Outcome of Henoch–Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset; https://cir.nii.ac.jp/crid/1360586972544054016; Successful Treatment of mesenteric vasculitis caused by henoch–Schönlein purpura with methylprednisolone pulse therapy; https://cir.nii.ac.jp/crid/1360586972544058368; Successful treatment of severe gastrointestinal manifestations of Henoch-Schonlein Purpura and factor XIII deficiency using cryoprecipitate transfusion; https://cir.nii.ac.jp/crid/1360586972544225536; Cerebral vasculitis in Henoch−Schönlein purpura: MRI and MRA findings, treated with plasmapheresis alone; https://cir.nii.ac.jp/crid/1360586972544326400; Intravenous immunoglobulin therapy for severe digestive manifestations of Henoch‐Schönlein purpura; https://cir.nii.ac.jp/crid/1360586972544564224; Successful Treatment of Henoch-Schönlein Purpura With Recurrent Gastrointestinal Involvement With Mycophenolate Mofetil; https://cir.nii.ac.jp/crid/1360586972544620416; Unusual presentation of Henöch-Schonlein purpura; https://cir.nii.ac.jp/crid/1360586972630321280; Henoch-Schönlein Purpura in children: not only kidney but also lung; https://cir.nii.ac.jp/crid/1360586974003638016; Cerebral vasculitis in Henoch-Schönlein purpura: a case report with sequential magnetic resonance imaging changes and treated with plasmapheresis alone; https://cir.nii.ac.jp/crid/1360586974511814272; Improved Outcome of Henoch-Schonlein Purpura Nephritis by Early Intensive Treatment; https://cir.nii.ac.jp/crid/1360586974511826304; A case of acute encephalophathy with residual neurological sequelae induced by immunoglobulin A vasculitis; https://cir.nii.ac.jp/crid/1360586974512028288; Refractory severe intestinal vasculitis due to Henoch-Schönlein Purpura: successful treatment with plasmapheresis; https://cir.nii.ac.jp/crid/1360586974512309376; Intravenous immunoglobulin for corticosteroid-resistant intestinal Henoch-Schönlein purpura: worth a controlled trial against corticosteroids?; https://cir.nii.ac.jp/crid/1360586974512422912; Gastrointestinal Symptoms of Henoch‐Schönlein Purpura Treated with Mycophenolate Mofetil; https://cir.nii.ac.jp/crid/1360586974512427392; Ranitidine administration in Henoch‐Schönlein vasculitis; https://cir.nii.ac.jp/crid/1360586974512765312; Primary antiphospholipid syndrome presenting as complicated Henoch-Schonlein purpura; https://cir.nii.ac.jp/crid/1360586974512806272; Sch�nlein-Henoch�s Syndrome in Children; https://cir.nii.ac.jp/crid/1360586974512835584; Epidemiology of biopsy-proven Henoch–Schönlein purpura nephritis in children: A nationwide survey in Japan; https://cir.nii.ac.jp/crid/1360586974512888064; Does Steroid Treatment of Abdominal Pain Prevent Renal Involvement in Henoch‐Schönlein Purpura?; https://cir.nii.ac.jp/crid/1360586975267464192; Successful treatment of gastrointestinal involvement in Henoch-Schönlein purpura with plasmapheresis; https://cir.nii.ac.jp/crid/1360586975267515008; A delayed diagnosis of late-onset pulmonary hemorrhage in a toddler with Henoch-Schönlein purpura after regression of skin rash; https://cir.nii.ac.jp/crid/1360586975268320256; Rare presentation of immunoglobulin A vasculitis as acute pancreatitis in a 10‐year‐old girl; https://cir.nii.ac.jp/crid/1360586975268538240; Atypical tumour-like involvement of the colon in Henoch-Schönlein purpura successfully treated with the administration of factor XIII; https://cir.nii.ac.jp/crid/1360586975268563456; Life-Threatening or Organ-Impairing Henoch-Schönlein Purpura: Plasmapheresis May Save Lives and Limit Organ Damage; https://cir.nii.ac.jp/crid/1360586975268597760; Acute renal insufficiency and pancreatitis in a child with atypical Henoch–Schönlein purpura: efficacy of a single dose of cyclophosphamide; https://cir.nii.ac.jp/crid/1360586975268685824; Focal Seizures and Posterior Reversible Encephalopathy Syndrome as Presenting Signs of IgA Vasculitis/Henoch-Schoenlein Purpura—An Educative Case and Systematic Review of the Literature; https://cir.nii.ac.jp/crid/1360586975268938880; Henoch-Schönlein Purpura /IgA Vasculitis Complicated by Coronary Artery Aneurysm: A Case Report and Literature Review; https://cir.nii.ac.jp/crid/1360586975269015808; Corticosteroids May Improve Clinical Outcomes During Hospitalization for Henoch-Schönlein Purpura; https://cir.nii.ac.jp/crid/1360586975730380032; EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria; https://cir.nii.ac.jp/crid/1360845538921468032; KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases; https://cir.nii.ac.jp/crid/1360861295380782592; Acute Scrotal Swelling in Henoch-Schonlein Purpura: Case Report and Review of the Literature; https://cir.nii.ac.jp/crid/1360868447901419776; Thrombosis warning in children suffering from Henoch-Schonlein Purpura; https://cir.nii.ac.jp/crid/1360868449025642112; Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura; https://cir.nii.ac.jp/crid/1361418518390798080; Tonsillectomy in the treatment of pediatric Henoch-Schönlein nephritis; https://cir.nii.ac.jp/crid/1361418518610071296; Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura; https://cir.nii.ac.jp/crid/1361418518755757056; Pathogenesis of Henoch-Schönlein purpura nephritis; https://cir.nii.ac.jp/crid/1361418520613538304; Severe hemorrhagic bullous lesions in Henoch Schonlein purpura: three pediatric cases and review of the literature; https://cir.nii.ac.jp/crid/1361699993368781440; Methylprednisolone or cyclosporine a in the treatment of Henoch-Schönlein nephritis: a nationwide study; https://cir.nii.ac.jp/crid/1361699993693142272; Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis; https://cir.nii.ac.jp/crid/1361699994571934208; Early Treatment with Methylprednisolone Pulse Therapy Combined with Tonsillectomy for Heavy Proteinuric Henoch-Schönlein Purpura Nephritis in Children; https://cir.nii.ac.jp/crid/1361699995619135744; Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children; https://cir.nii.ac.jp/crid/1361981469145152768; Pulmonary Hemorrhage Associated with Henoch-Schönlein Purpura in Pediatric Patients: Case Report and Review of the Literature; https://cir.nii.ac.jp/crid/1361981469709353600; Plasmapheresis therapy for rapidly progressive Henoch-Sch�nlein nephritis; https://cir.nii.ac.jp/crid/1362262944582445312; Henoch-Schönlein purpura: a case with atypical presentation; https://cir.nii.ac.jp/crid/1362262945159121152; Clinical outcome of Schönlein-Henoch purpura nephritis in children; https://cir.nii.ac.jp/crid/1362262946332852480; Cyclosporine A vs. methylprednisolone for Henoch–Schönlein nephritis: a randomized trial; https://cir.nii.ac.jp/crid/1362544418482969216; The American College of Rheumatology 1990 criteria for the classification of henoch‐schönlein purpura; https://cir.nii.ac.jp/crid/1362544419737501568; Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP); https://cir.nii.ac.jp/crid/1362544419814576768; Severe Mitral Regurgitation in a Child With Henoch-Schönlein Purpura and Pulmonary Hemorrhage; https://cir.nii.ac.jp/crid/1362825893740706816; Activity of blood coagulation Factor XIII as a prognostic indicator in patients with Henoch-Sch�nlein purpura; https://cir.nii.ac.jp/crid/1362825894995190912; Pulmonary Hemorrhage: An Often Fatal Complication of Henoch‐Schoenlein Purpura; https://cir.nii.ac.jp/crid/1363107369755970048; Clinical evaluation of a pasteurized factor XIII concentrate administration in Henoch-Schönlein purpura; https://cir.nii.ac.jp/crid/1363388844610364160; Treating severe Henoch-Schönlein and IgA nephritis with plasmapheresis alone; https://cir.nii.ac.jp/crid/1363388846114519552; Immunoglobulin A Nephropathies in Children (Includes HSP); https://cir.nii.ac.jp/crid/1363670319368702848; FACTOR XIII (FIBRIN STABILISING FACTOR) IN HENOCH‐SCHÖNLEIN'S PURPURA; https://cir.nii.ac.jp/crid/1363670319375600512; Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue; https://cir.nii.ac.jp/crid/1363951795228437632; Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis.; https://cir.nii.ac.jp/crid/1363951795345843712; Efficacy of Methylprednisolone and Urokinase Pulse Therapy for Severe Henoch-Schönlein Nephritis; https://cir.nii.ac.jp/crid/1364233270089832192; A CASE OF HENOCH-SCHOENLEIN PURPURA NEPHRITIS RECURRING AFTER 3 YEARS REMISSION; https://cir.nii.ac.jp/crid/1390001206305057920; EFFICACY OF CYCLOSPORINE A FOR STEROID-RESISTANT SEVERE HENOCH-SCH^|^Ouml;NLEIN PURPURA NEPHRITIS; https://cir.nii.ac.jp/crid/1390001206305920896; Clinical Significance of Blood Coagulation Factor XIII Activity in Adult Henoch-Sch&ouml;nlein Purpura; https://cir.nii.ac.jp/crid/1390282680072840832; Preventive Effect of Tonsillectomy on Recurrence of Henoch-Schönlein Purpura Nephritis after Intravenous Methylprednisolone Pulse Therapy; https://cir.nii.ac.jp/crid/1390565134823985024
• 連携機関・データベース: 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/
• 提供元機関・データベース: Japan Link Center; https://japanlinkcenter.org/top; Crossref; https://www.crossref.org

• 要約等: <p>IgA血管炎は，皮膚症状・関節症状・腹部症状を三主徴とする小児に好発する血管炎であり，一般小児科診療の現場においても遭遇することの多い疾患である．また約30%の症例において長期予後を規定する重要な合併症である紫斑病性腎炎を認める．小児紫斑病性腎炎の重症例では腎生検による評価が必要であり，その重...